Lisa Antonia Dröge

Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine

Lisa Antonia Dröge, F. H. Perschel, Natalia Stütz et al. · Hypertension · 2020 · 141 citations

Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction

Ignacio Herraı̀z, Lisa Antonia Dröge, Enery Gómez‐Montes et al. · Obstetrics and Gynecology · 2014 · 94 citations

Fertility, Human Growth, Fetal Medicine +25

A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes

Leon J. Schmidt, Mark Neznansky, Max Hackelöer et al. · American Journal of Obstetrics and Gynecology · 2022 · 75 citations

Machine Learning, Preeclampsia, Maternal Cardiovascular Outcome +12

Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy

Stefan Verlohren, F. H. Perschel, B. Thilaganathan et al. · Hypertension · 2017 · 73 citations

Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®

Lisa Antonia Dröge, Alice Höller, Laura Ehrlich et al. · Pregnancy Hypertension · 2017 · 20 citations

Fetal Growth Restriction, Fertility, Fetal Medicine +15